December 21, 2010
The worldwide market for home health monitoring of "welfare diseases" was worth about € 7.6 billion ($10 billion) in 2010, according to Berg Insight. The conditions most commonly treated via these remote monitoring services include diabetes, cardiac arrhythmia, sleep apnea, asthma and chronic obstructive pulmonary disease (COPD), the report found. More than 200 million people in the EU and the US...
September 25, 2009
The market for home health monitoring of chronic diseases was worth about $11 billion last year, according to a report from Berg Insight. The analyst firm estimates that the market is growing about 10 percent annually. Berg estimates that some 300 million people in the EU and the US have at least one chronic disease that may benefit from home health monitoring.
Of those 300 million people, Berg...